Kailera clinical trial pipeline

4 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 3 with minor changes only.

1. Notable

   Impact of Renal Impairment on the Pharmacokinetics (PK) of…Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

   Recruitment opened

   Kailera·Phase 1· NCT07793929· Registry history of NCT07793929 on ClinicalTrials.gov (opens the registry)

   Oct 1, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.